Litigation Details for AstraZeneca AB v. Alkem Laboratories Limited (D. Del. 2022)
✉ Email this page to a colleague
AstraZeneca AB v. Alkem Laboratories Limited (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-03-18 |
Court | District Court, D. Delaware | Date Terminated | 2022-06-24 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,300,065; RE46,276 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Alkem Laboratories Limited
Details for AstraZeneca AB v. Alkem Laboratories Limited (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-03-18 | 3 | ANDA Form | , 2022. Date of Expiration of Patent: RE46,276 - 10/30/2024; 10,300,065 - 1/27/2036. Thirty Month Stay… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2022 24 June 2022 1:22-cv-00354 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-03-18 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,276 ;10,300,065. (srs) (Entered…2022 24 June 2022 1:22-cv-00354 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |